This site is intended for health professionals only

Editor’s pick

Epileptic children denied cheap drug
Epileptic children denied cheap drug
Regulators “urged stronger Avandia label”
Regulators “urged stronger Avandia label”
Antipsychotics linked to mortality risk
Antipsychotics linked to mortality risk
Pfizer outlines oncology plans
Pfizer outlines oncology plans
Will Velcade deal set future pattern?
Will Velcade deal set future pattern?
Funder bias in trial outcomes
Funder bias in trial outcomes
Cisplatin tops carboplatin against NSCLC?
Cisplatin tops carboplatin against NSCLC?
Erbitux benefit in mCRC claimed
Erbitux benefit in mCRC claimed
Doubt remains on Avandia
Doubt remains on Avandia
HRT risk: jury still out
HRT risk: jury still out
Chemotherapy cuts liver metastasis recurrence
Chemotherapy cuts liver metastasis recurrence
Study backs NSCLC findings
Study backs NSCLC findings
1 … 261 262 263 264 265 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x